JAY GRAY: Open Payments
NPI 1205211497 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,115 in 125 payments from 20 companies in 2025. Trend: 2023 $2,925 · 2024 $3,294 · 2025 $2,115
Food & beverage: $2,115
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $359 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $252 |
| UCB, Inc. | 10 | $244 |
| Incyte Corporation | 11 | $222 |
| Novartis Pharmaceuticals Corporation | 10 | $207 |
| Amgen Inc. | 9 | $147 |
| Regeneron Healthcare Solutions, Inc. | 4 | $106 |
| Janssen Biotech, Inc. | 5 | $75 |
| LEO Pharma Inc. | 3 | $68 |
| Lilly USA, LLC | 4 | $66 |
Products named: RINVOQ, Bimzelx, OPZELURA, OTEZLA, DUPIXENT, COSENTYX, ILUMYA, SKYRIZI.
Industry payments across KS — which companies pay providers there.
